Stock Stock: [ATR]: Aptargroup
Aptar is a US packaging company that is global leader in drug delivery, consum...
Renforth Resources, Inc. (OTCQB: RFHRF) (CSE: RFR)
Keynote speaker: Nicole Br...
General Allarity Therapeutics to US Nasdaq
Sweden’s stock market is a forgotten fraction in comparison to most other mark...
News & Blogs Blog: Musk’s Trip to Beijing After India Snub Shows Power of China
A snub like that could hurt India's pride, and if one has read biographies of ...
Renforth Resources, President and CEO, Nicole Brewster joins us for this year&...
edgeinvest . 2024-10-31
edgeinvest . 2024-10-31
Visa to Lay Off Around 1,400 Employees and Contractors, WSJ Reports
edgeinvest . 2024-10-31
Intel Set for Big Drop in Quarterly Revenue as Chipmaker Struggles to Bounce Back
edgeinvest . 2024-10-31
edgeinvest . 2024-10-31
edgeinvest . 2024-10-31
US Hiring in ADP Data Rises to Fastest Pace in More Than a Year
edgeinvest . 2024-10-31
edgeinvest . 2024-10-31
edgeinvest . 2024-10-30
edgeinvest . 2024-10-30
Meta Developing Its Own AI Search Engine, the Information Reports
Gainers
2,807
Losers
7,182
Unchanged
954
Untraded
230
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Price Target
Firm
12
1
CEO Morning Brief
2
3
CEO Morning Brief
4
CEO Morning Brief
5
CEO Morning Brief
#
Stock
Score
Cramer picks his top Dow stock for 2017
Even though the Dow Jones industrial average didn't hit 20,000 in 2016, Jim Cramer found three s...
5 stocks to buy in 2017 - CNN Money
As the world prepares to welcome 2017, investors are asking, "What now?" The stock market i...
Top 10 Tech Stock Predictions for 2017 - TheStreet
Perhaps no sector is as prone to seeing wide-eyed predictions about massive changes that are about t...
Top 10 Stock Picks for 2017 - Barrons
Equity investors face a big choice for 2017. Bet on appreciated "Trump" stocks in the hopes ...
Best Tech Stocks to Buy for 2017
Going into 2017, technology is seeping into almost every aspect of everyday life. From retail to tra...
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....